Fengming Yi
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Epigenetics and DNA Methylation 3
- Renal and related cancers 2
-
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Co-authors
- Bing Xia (9 shared papers)Wenxiong Zhang (24 shared papers)Yiping Wei (20 shared papers)Jie Zhao (4 shared papers)Feng Zhou (4 shared papers)Youqing Zhu (1 shared paper)Zhifen Chen (1 shared paper)Long Feng (9 shared papers)
- Journals
- World Journal of Surgical Oncology (4 papers)Chemotherapy (3 papers)Medicine (3 papers)Frontiers in Oncology (3 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fengming Yi
51 papers receiving 744 citations
Peers
Comparison fields: 5 of 79
- Hepatology 69
- Oncology 164
- Cancer Research 72
- Surgery 179
- Pulmonary and Respiratory Medicine 113
Countries citing papers authored by Fengming Yi
This map shows the geographic impact of Fengming Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengming Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengming Yi more than expected).
Fields of papers citing papers by Fengming Yi
This network shows the impact of papers produced by Fengming Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengming Yi. The network helps show where Fengming Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengming Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 119 | |
| 2 | 2014 | 69 | |
| 3 | Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis. | 2019 | 37 |
| 4 | 2013 | 35 | |
| 5 | 2010 | 30 | |
| 6 | 2019 | 30 | |
| 7 | 2013 | 26 | |
| 8 | 2013 | 26 | |
| 9 | 2023 | 24 | |
| 10 | 2020 | 21 | |
| 11 | 2019 | 21 | |
| 12 | 2019 | 19 | |
| 13 | 2021 | 17 | |
| 14 | 2012 | 17 | |
| 15 | 2014 | 17 | |
| 16 | 2019 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2025 | 15 | |
| 19 | 2020 | 15 | |
| 20 | 2020 | 13 |
About Fengming Yi
Fengming Yi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Hepatology, having authored 54 papers that have together received 756 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Gastric Cancer Management and Outcomes (5 papers), Inflammatory Bowel Disease (5 papers), Lung Cancer Research Studies (3 papers), Epigenetics and DNA Methylation (3 papers), Lung Cancer Treatments and Mutations (3 papers), Renal cell carcinoma treatment (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Hepatology (69 citations), Oncology (164 citations), Cancer Research (72 citations), Surgery (179 citations) and Pulmonary and Respiratory Medicine (113 citations). Fengming Yi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bing Xia, Wenxiong Zhang, Yiping Wei, Jie Zhao, Feng Zhou, Youqing Zhu, Zhifen Chen, Long Feng, Sha Huang and Jun Lei. Their work appears in journals such as World Journal of Surgical Oncology, Chemotherapy, Medicine, Frontiers in Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.